Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Profile Treatment Approach Name | JAK2 Inhibitor - ATP competitive |
Profile Name | JAK2 fusion |
Drug Class | JAK2 Inhibitor - ATP competitive 15 |
Therapy |
PubMed Id | Reference Title | Details |
---|---|---|
(23630205) | Efficacy of ruxolitinib in chronic eosinophilic leukemia associated with a PCM1-JAK2 fusion gene. | Full reference... |
(29296813) | Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL. | Full reference... |
(32279331) | Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes. | Full reference... |
(34376782) | Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia. | Full reference... |